FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

407801001: Product containing precisely agalsidase beta 35 milligram/1 vial powder for conventional release solution for injection (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3689386011 Agalsidase beta 35 mg powder for solution for injection vial en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3689387019 Product containing precisely agalsidase beta 35 milligram/1 vial powder for conventional release solution for injection (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Agalsidase beta 35 mg powder for solution for injection vial est un(e) (attribut) Agalsidase beta only product in parenteral dose form true Inferred relationship Some
Agalsidase beta 35 mg powder for solution for injection vial est un(e) (attribut) agalsidase bêta false Inferred relationship Some
Agalsidase beta 35 mg powder for solution for injection vial a pour principe actif (attribut) Alpha-galactosidase false Inferred relationship Some
Agalsidase beta 35 mg powder for solution for injection vial a une forme pharmaceutique (attribut) Injection false Inferred relationship Some
Agalsidase beta 35 mg powder for solution for injection vial a pour principe actif (attribut) agent biologique false Inferred relationship Some
Agalsidase beta 35 mg powder for solution for injection vial a pour principe actif (attribut) Agalsidase beta (substance) false Inferred relationship Some
Agalsidase beta 35 mg powder for solution for injection vial est un(e) (attribut) Product manufactured as parenteral dose form (product) false Inferred relationship Some
Agalsidase beta 35 mg powder for solution for injection vial a une forme pharmaceutique (attribut) Powder for solution for injection true Inferred relationship Some
Agalsidase beta 35 mg powder for solution for injection vial Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 1
Agalsidase beta 35 mg powder for solution for injection vial Count of base of active ingredient un false Inferred relationship Some
Agalsidase beta 35 mg powder for solution for injection vial Has precise active ingredient Agalsidase beta (substance) true Inferred relationship Some 1
Agalsidase beta 35 mg powder for solution for injection vial Has basis of strength substance (attribute) Agalsidase beta (substance) true Inferred relationship Some 1
Agalsidase beta 35 mg powder for solution for injection vial Has presentation strength denominator unit (attribute) Vial (unit of presentation) true Inferred relationship Some 1
Agalsidase beta 35 mg powder for solution for injection vial Has unit of presentation Vial (unit of presentation) true Inferred relationship Some
Agalsidase beta 35 mg powder for solution for injection vial Has presentation strength numerator value (attribute) 35 (qualifier value) false Inferred relationship Some 1
Agalsidase beta 35 mg powder for solution for injection vial Has presentation strength denominator value un false Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start